Akari Therapeutics (AKTX) Tax Rate (2025 - 2026)

Akari Therapeutics (AKTX) reported Tax Rate of 5.61% for Q1 2026, up 444.01% sequentially from 1.63% in Q4 2025.

Akari Therapeutics (AKTX) Tax Rate (2025 - 2026) Analysis & Trends

Akari Therapeutics (AKTX) has 2 years of Tax Rate data on file, last reported at 5.61% in Q1 2026.

For the quarter ending Q1 2026, Tax Rate changed N/A year-over-year to 5.61%; the trailing twelve-month figure through Mar 2026 stood at 5.96% (changed N/A YoY), and the FY2025 full-year result was 5.48%, changed N/A from the prior year.
Tax Rate climbed to 5.61% in Q1 2026, from 1.63% in the prior quarter.
In the past five years, Tax Rate ranged from a high of 14.53% in Q3 2025 to a low of 1.63% in Q4 2025.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-0.34
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	5.61
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	12.29
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	17.68
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	12.51
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-13.70
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Alnylam Pharmaceuticals	36.08 Bn	33.07 Bn	959.66 Mn	7.07

Historic Data

Download Data

Date	Value
Mar 31, 2026	5.61
Mar 31, 2026	5.61
Mar 31, 2026	5.61
Dec 31, 2025	-1.63
Dec 31, 2025	-1.63
Dec 31, 2025	-1.63
Sep 30, 2025	14.53
Sep 30, 2025	14.53
Sep 30, 2025	14.53